Protivovospalitel'noe i protivovirusnoe deystvie intranazal'nogo spreya Euforbium kompozitum:perspektivy i osobennosti terapii rinitov i rinosinusitov


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a review of clinical studies on the efficacy and safety of the intranasal spray Euphorbium compositum. Spray for nasal application is an alternative to traditional drugs used for the treatment of rhinitis and sinusitis, which has no side effects and limitations characteristic for these drugs. Best tolerability compared with xylometazoline allows to recommend Euphorbium compositum as a drug for the long-term treatment of chronic sinusitis. The complex mechanism of action of the drug provides its anti-viral and antiinflammatory activity.

Full Text

Restricted Access

About the authors

A. A Mar'yanovskiy

References

  1. Weiser M., Clasen B.P.E. Randomized placebo controlled double-blind study of the clinical efficacy of the homeopathic Euphorbium compositum S-Nasal Spray in cases of chronic sinusitis. Forsch Komplementörmed Klass Naturheilkd. 1994;1:251-59. English translation in: Biol. Ther. 1995;1:4-11.
  2. Zenner S., Metelmann H. Therapeutic Experiences with a Homeopathic Nasal Spray. Hufeland J. 1992;3:67-74.
  3. Gottwald R., Weiser M. Antihomotoxic treatment of chronic sinusitis: results of a drug monitoring study with Euphorbium compositum S Drops. Translated from Medicina Biologica. 2000;13(3):84-7.
  4. Sprenger F. A study with Euphorbium compositum nasal drops (metered dose spray without propellant gas). J. General Practice. 1984;60(27):1164-68.
  5. Connert W.D., Maiwald J. Therapie chronisch-medikamentös und vasormotorisch bedingter rhinopathien. Erfahrungen mit einem biotherapeutischen nasenspray. Therapiewoche. 1987;37:1179-86. English translation available in: Connert W.D., Maiwald J. The therapy of rhinopathy: results of application of a biotherapeutic nasal spray. Biol. Therapy 1991;9(4):182-92.
  6. Weiser M., Gottwald R. Homöopathische Nasentropfen lassen bei Kindern Rhinitis und Sinusitis schneller abklingen. Therapeutische Mitteilungen. Gesundes Leben. 1999;6:63.
  7. Ammerschlager H., Klein P., Weiser M., Oberbaum M. Treatment of infl ammatory diseases of the upper respiratory tract - comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementörmed Klass Naturheilkd. 2005;12:24-31.
  8. Urlea-Schön M.I. Effectiveness and tolerability of Euphorbium comp SN for the symptomatic treatment of rhinitis in children aged 2-6 years. Eur. J. Int. Med. 2009;1:236 (Abstract PO-023).
  9. Data on fi le, Raab V. Practice report. Further therapeutic experience with Euphorbium compositum nasal drops (metered dose spray without propellant gas) in ENT practice. Biologische Medizin. 1982;4:176-79.
  10. Glatthaar-Saalmüller B., Fallier-Becker P. Antiviral action of Euphorbium compositum and its components. Forsch Komplementаrmed Klass Naturheilkd. 2001;4:207-12.
  11. Glatthaar-Saalmüller B., et al. Euphorbium compositum: viruses of the upper respiratory tract inhibited. Biologische Medizin. 2002;4:194-95.
  12. Metelmann H., Glatthaar-Saalmüller B. Antiviral action of a homeopathic medication. Biomed Ther. 2000; 18(1):160-64.
  13. Schmolz M., Metelmann H. Modulation of cytokine synthesis in human leukocytes by individual components of a combination homeopathic nasal spray. Biol. Ther. 1999;17(2):61-63:75.
  14. Dykewicz M.S., Hamilos D.L. Rhinitis and sinusitis. J. Allergy Clin. Immunol. 2010;125(2 Suppl 2):S103-15.
  15. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F., Cohen N., Cervin A., Douglas R., Gevaerts P., Georgalas C., Goossens H., Harvey R., Hellings P., Hopkins C., Jones N., Joos G., Kalogjera L., Kern B., Kowalski M., Price D., Riechelmann H., Schlosser R., Senior B., Thomas M., Toskala E., Voegels R., Wang D.Y., Wormald P.J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. 2012; 50(Suppl 23):1-298.
  16. Wallace D.V., Dykewicz M.S., Bernstein D.I., Blessing-Moore J., Cox L., Khan D.A., Lang D.M., Nicklas R.A, Oppenheimer J., Portnoy J.M., Randolph C.C., Schuller D., SpectorS.L., Tilles S.A. Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J. Allergy Clin. Immunol. 2008; 122(2 Suppl):S1-84.
  17. Rosenfeld R.M., Andes D., Bhattacharyya N., Cheung D., Eisenberg S., Ganiats T.G., Gelzer A., HamilosD.,HaydonR.C.3rd,HudginsP.A.,JonesS., Krouse H.J., Lee L.H., Mahoney M.C., Marple B.F., Mitchell C.J., Nathan R., Shiffman R.N., Smith T.L., Witsell D.L. Clinical practice guideline: adult sinusitis. Otolaryngol. Head Neck Surg. 2007;137(3 Suppl):S1-31.
  18. Settipane R.A., Charnock D.R. Epidemiology of rhinitis: allergic and nonallergic. Clin. Allergy Immunol. 2007;19:23-34.
  19. Hamilos D.L. Chronic rhinosinusitis patterns of illness. Clin. Allergy Immunol. 2007;20:1-13.
  20. Mattos J.L., Woodard C.R., Payne S.C. Trends in common rhinologic illnesses: analysis of U.S. healthcare surveys 1995-2007. Int. Forum Allergy Rhinol. 2011;1(1):3-12.
  21. Punekar Y.S., Sheikh A. Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices. Clin. Exp. Allergy. 2009;39(8): 1209-216.
  22. Ghouri N., Hippisley-Cox J., Newton J., Sheikh A. Trends in the epidemiology and prescribing of medication for allergic rhinitis in England. J. R. Soc. Med. 2008;101(9):466-72.
  23. Klossek J.M., Annesi-Maesano I., Pribil C., Didier A. [INSTANT: national survey of allergic rhinitis in a French adult population based-sample]. Presse Med. 2009;38(9):1220-29.
  24. Quercia O., Incorvaia C., Puccinelli P., Scurati S., Emiliani F., Frati F., Stefanini G.F. Prevalence of allergic disorders in Italy: the Cotignola population study. Eur. Ann. Allergy Clin. Immunol. 2012;44(1):5-11.
  25. Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am. J. Rhinol. Allergy. 2012;26(2):120-22.
  26. Hastan D., Fokkens W.J., Bachert C., Newson R.B., Bislimovska J., Bockelbrink A., Bousquet P.J., Brozek G., Bruno A., Dahlen S.E., Forsberg B., Gunnbjörnsdottir M., Kasper L., Kramer U., Kowalski M.L., Lange B., Lundback B., Salagean E., Todo-Bom A., Tomassen P., Toskala E., van Drunen C.M., Bousquet J., Zuberbier T., Jarvis D., Burney P. Chronic rhinosinusitis in Europe - an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216-23.
  27. Jarvis D., Newson R., Lotvall J., Hastan D., Tomassen P., Keil T., Gjomarkaj M., Forsberg B., Gunnbjornsdottir M., Minov J., Brozek G., Dahlen S.E., Toskala E., Kowalski M.L., Olze H., Howarth P., Kramer U., Baelum J., Loureiro C., Kasper L., Bousquet P.J., Bousquet J., Bachert C., Fokkens W., Burney P. Asthma in adults and its association with chronic rhinosinusitis: the GA(2)LEN survey in Europe. Allergy. 2012;67( 1 ):91 -8.
  28. Skoner D.P. Complications of allergic rhinitis. J. Allergy Clin. Immunol. 2000;105(6 Pt 2): S605-609.
  29. Cruz A.A., Popov T., Pawankar R., Annesi-Maesano I., Fokkens W., Kemp J., Ohta K., Price D., Bousquet J. ARIA Initiative Scientifi c Committee. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62(Suppl 84):1-41.
  30. deGroot E.P., Nijkamp A., Duiverman E.J., Brand P.L. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax 2012; Jan 2. [Epub ahead of print].
  31. Dixon A.E. Rhinosinusitis and asthma: the missing link. Curr. Opin. Pulm. Med. 2009;15(1):19-24.
  32. Lunn M., Craig T. Rhinitis and sleep. Sleep Med. Rev. 2011;15(5):293-99.
  33. Meltzer E.O., Nathan R., Derebery J., Stang P.E., Campbell U.B., Yeh W.S., Corrao M., Stanford R. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2009;30(3):244-54.
  34. Craig T.J., Ferguson B.J., Krouse J.H. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am. J. Otolaryngol. 2008;29(3):209-17.
  35. Hartgerink-Lutgens I., Vermeeren A., Vuurman E., Kremer B. Disturbed cognitive functions after nasal provocation in patients with seasonal allergic rhinitis. Clin. Exp. Allergy. 2009;39(4):500- 08.
  36. Meltzer E.O., Gross G.N., Katial R., Storms W.W. Allergic rhinitis substantially impacts patient quality of life: fi ndings from the Nasal Allergy Survey Assessing Limitations. J. Fam. Pract. 2012;61(2 Suppl):S5-10.
  37. Nathan R.A. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28(1):3-9.
  38. Blaiss M.S. Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc. 2008;29(1):1-6.
  39. Vuurman E.F., van Veggel L.M., Uiterwijk M.M., Leutner D., O'Hanlon J. F. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann. Allergy. 1993;71(2):121-26.
  40. Willsie S.K. Improved strategies and new treatment options for allergic rhinitis. J. Am. Osteopath Assoc. 2002;102(6 Suppl 2):S7-14.
  41. Puchelle E., Zahm J.M., Tournier J.M., Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006;3(8):726-33.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies